Funding granted for a clinical trial on the effects of a DTx in breast cancer treatment

ScientificMed, together with researchers and clinicians from three hospitals in Stockholm, has been granted funding from the Swedish Breast Cancer Association (Bröstcancerförbundet) for a clinical trial (RCT) targeting women with endocrine adjuvant therapy breast cancer.

The purpose of the RCT is to study whether using a Digital Therapeutic (DTx) as support increase adherence to adjuvant endocrine therapy, reduce the late effects of treatment and increase quality of life. The secondary aims are to study health economic effects, compliance to usage of the app and its perceived usability.

For further information, please contact Jan Fjellström, ScientificMed, +46 708 63 60 00.